NS3/4A protease inhibitors (Novalex Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNS3/4A protease inhibitors (Novalex Therapeutics)
Drug Alias NameNS3/4A protease inhibitors (University of Illinois)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovalex Therapeutics IncUniversity Of Illinois
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A